AlzChem Group AG (DE:ACT)
XETRA:ACT
Holding DE:ACT?
Track your performance easily

AlzChem Group AG (ACT) Income Statement

2 Followers

AlzChem Group AG Income Statement

Last quarter (Q4 2022), AlzChem Group AG's total revenue was €133.20M, an increase of 19.94% from the same quarter last year. In Q4, AlzChem Group AG's net income was €6.83M. See AlzChem Group AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
€ 542.22M€ 542.22M€ 422.29M€ 379.26M€ 376.07M€ 375.22M
Cost of Revenue
€ 257.54M€ 259.50M€ 153.96M€ 128.68M€ 138.79M€ 143.05M
Gross Profit
€ 284.68M€ 282.72M€ 268.34M€ 250.58M€ 237.28M€ 232.17M
Operating Expense
€ 255.70M€ 252.16M€ 230.80M€ 218.07M€ 207.03M€ 192.41M
Operating Income
€ 28.98M€ 30.57M€ 37.54M€ 32.52M€ 30.25M€ 39.76M
Net Non Operating Interest Income Expense
€ 5.38M€ 5.38M€ -1.06M€ -3.51M€ -5.09M€ -2.27M
Other Income Expense
------
Pretax Income
€ 41.28M€ 41.28M€ 36.51M€ 27.20M€ 25.49M€ 31.92M
Tax Provision
€ 11.06M€ 11.06M€ 8.75M€ 7.33M€ 7.34M€ 9.14M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
€ 30.05M€ 30.05M€ 27.59M€ 19.69M€ 17.98M€ 22.64M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
-----€ 2.19M
Total Expenses
€ 513.24M€ 511.66M€ 384.75M€ 346.74M€ 345.82M€ 335.46M
Net Income From Continuing And Discontinued Operation
€ 30.05M€ 30.05M€ 27.59M€ 19.69M€ 17.98M€ 22.64M
Normalized Income
€ 30.05M€ 26.22M€ 27.59M€ 19.69M€ 17.98M€ 26.79M
Interest Expense
€ 3.03M€ 3.03M€ 1.70M€ 3.83M€ 5.36M€ 2.66M
EBIT
€ 44.31M€ 44.31M€ 38.22M€ 31.03M€ 30.85M€ 34.58M
EBITDA
€ 69.86M€ 69.86M€ 62.69M€ 54.13M€ 50.34M€ 49.76M
Currency in EUR

AlzChem Group AG Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis